1
|
Bowen A, Gómez-Trillos S, Curran G, Graves KD, Sheppard VB, Schwartz MD, Peshkin BN, Campos C, Garcés N, Dash C, Aburto L, Valencia-Rojas N, Hernández G, Villa A, Cupertino P, Carrera P, Hurtado-de-Mendoza A. Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community-based organizations. J Genet Couns 2023; 32:965-981. [PMID: 37062905 PMCID: PMC10577152 DOI: 10.1002/jgc4.1705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Revised: 02/22/2023] [Accepted: 03/13/2023] [Indexed: 04/18/2023]
Abstract
Genetic counseling and testing (GCT) inform cancer management for persons at risk for hereditary breast and ovarian cancer (HBOC). Community-based organizations (CBOs) may play a role in identifying at-risk Latinx individuals to connect them to GCT but data are lacking. Two academic centers and their four CBO partners planned to implement a validated questionnaire for HBOC risk screening ("HBOC risk screening tool"). This study aimed to assess CBO's preferences for HBOC risk screening tools, as well as the barriers and facilitators anticipated for future implementation. Pre-implementation focus groups were conducted with CBO's staff. Discussions centered on current practices to identify and refer at-risk patients. During the discussion, staff were asked to select one out of five validated HBOC risk screening tools to implement and to discuss anticipated barriers/facilitators for implementation. The four focus groups were coded and qualitative analyzed following the Consolidated Framework for Implementation Research (CFIR) and Health Equity domains. All CBOs chose the Family History Screen 7 (FHS-7). Participants (N = 35) highlighted how the FHS-7 was easy to adapt to better fit the target population and changing guidelines. They had positive attitudes toward implementing the screening tool, stressed how the culture of the organization positioned them to reach the target population, and noted barriers in different CFIR domains (e.g., low knowledge about HBOC and GCT referrals; scarce available resources). Participants pointed to barriers related to health equity domains including limited access to GCT and follow-up care for uninsured and underinsured populations, challenges obtaining accurate family history, and immigration-related barriers. CBOs highlighted the importance of partnering with other stakeholders to overcome barriers. Findings emphasize the need to develop multi-level implementation strategies to overcome barriers and leverage facilitators. This study can inform the development of implementation toolkits for CBOs to implement HBOC screening tools to advance health equity.
Collapse
Affiliation(s)
| | - Sara Gómez-Trillos
- Georgetown University Medical Center, Washington, District of Columbia, USA
- Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Cancer Genomics Research, Washington, District of Columbia, USA
| | - Geoffrey Curran
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
| | - Kristi D. Graves
- Georgetown University Medical Center, Washington, District of Columbia, USA
- Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Cancer Genomics Research, Washington, District of Columbia, USA
| | | | - Marc D. Schwartz
- Georgetown University Medical Center, Washington, District of Columbia, USA
- Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Cancer Genomics Research, Washington, District of Columbia, USA
| | - Beth N. Peshkin
- Georgetown University Medical Center, Washington, District of Columbia, USA
- Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Cancer Genomics Research, Washington, District of Columbia, USA
| | | | - Nathaly Garcés
- Georgetown University Medical Center, Washington, District of Columbia, USA
| | - Chiranjeev Dash
- Georgetown University Medical Center, Washington, District of Columbia, USA
| | | | | | | | - Antonio Villa
- Virginia Commonwealth University, Richmond, Virginia, USA
- La Casa de la Salud, Richmond, Virginia, USA
| | - Paula Cupertino
- University of Rochester Medical Center, Rochester, New York, USA
| | | | - Alejandra Hurtado-de-Mendoza
- Georgetown University Medical Center, Washington, District of Columbia, USA
- Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Cancer Genomics Research, Washington, District of Columbia, USA
| |
Collapse
|
2
|
Guan Y, McBride CM, Pathak S, Gornick MC. Just Dissemination of Genomics-Informed Public Health Applications: Time to Deepen Our Public Engagement Approaches. Public Health Genomics 2023; 26:165-170. [PMID: 37703856 PMCID: PMC10614502 DOI: 10.1159/000534080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2023] [Accepted: 09/08/2023] [Indexed: 09/15/2023] Open
Affiliation(s)
- Yue Guan
- Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
| | - Colleen M McBride
- Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
| | - Sarita Pathak
- Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
| | - Michele C Gornick
- Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
| |
Collapse
|
3
|
Zhao J, McBride CM, Campbell GP, Pentz RD, Escoffery C, Konomos M, Bellcross C, Ward K, Shepperd JR, Guan Y. Your Family Connects: A Theory-Based Intervention to Encourage Communication about Possible Inherited Cancer Risk among Ovarian Cancer Survivors and Close Relatives. Public Health Genomics 2023; 26:77-89. [PMID: 37487468 PMCID: PMC10614520 DOI: 10.1159/000531772] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2022] [Accepted: 06/26/2023] [Indexed: 07/26/2023] Open
Abstract
INTRODUCTION Encouraging family communication about possible genetic risk has become among the most important avenues for achieving the full potential of genomic discovery for primary and secondary prevention. Yet, effective family-wide risk communication (i.e., conveying genetic risk status and its meaning for other family members) remains a critical gap in the field. We aim to describe the iterative process of developing a scalable population-based communication outreach intervention, Your Family Connects, to reach ovarian cancer survivors and close relatives to communicate the potential for inherited risk and to consider genetic counseling. METHODS Relational-level theories (e.g., interdependence theory) suggest that interventions to promote family cancer risk communication will be most effective if they consider the qualities of specific relationships and activate motives to preserve the relationship. Informed by these theories, we collaborated with 14 citizen scientists (survivors of ovarian cancer or relatives) and collected 261 surveys and 39 structured interviews over 12 weeks of citizen science activities in 2020. RESULTS The citizen science findings and consideration of relational-level theories informed the content and implementation of Your Family Connects (www.yourfamilyconnects.org). CS results showed survivors favor personal contact with close relatives, but relatives were open to alternative contact methods, such as through health professionals. Recognizing the need for varied approaches based on relationship dynamics, we implemented a relative contact menu to enable survivors identify at-risk relatives and provide multiple contact options (i.e., survivor contact, health professional contact, and delayed contact). In line with relational autonomy principles, we included pros and cons for each option, assisting survivors in choosing suitable contact methods for each relative. DISCUSSION Our developed intervention represents a novel application of relational-level theories and partnership with citizen scientists to expand genetic services reach to increase the likelihood for fair distribution of cancer genomic advances. The Your Family Connects intervention as part of a randomized trial in collaboration with the Georgia Cancer Registry compared with standard outreach.
Collapse
Affiliation(s)
- Jingsong Zhao
- Department of Behavioral, Social and Health Education Sciences, Emory University, Atlanta, Georgia, USA,
| | - Colleen M McBride
- Department of Behavioral, Social and Health Education Sciences, Emory University, Atlanta, Georgia, USA
| | - Gavin P Campbell
- Department of Behavioral, Social and Health Education Sciences, Emory University, Atlanta, Georgia, USA
| | - Rebecca D Pentz
- Department of Hematology and Oncology, Emory School of Medicine, Atlanta, Georgia, USA
| | - Cam Escoffery
- Department of Behavioral, Social and Health Education Sciences, Emory University, Atlanta, Georgia, USA
| | | | | | - Kevin Ward
- Georgia Center for Cancer Statistics, Emory University, Atlanta, Georgia, USA
| | - James R Shepperd
- Department of Psychology, University of Florida, Gainesville, Florida, USA
| | - Yue Guan
- Department of Behavioral, Social and Health Education Sciences, Emory University, Atlanta, Georgia, USA
| |
Collapse
|
4
|
Theory Designed Strategies to Support Implementation of Genomics in Nephrology. Genes (Basel) 2022; 13:genes13101919. [PMID: 36292804 PMCID: PMC9601730 DOI: 10.3390/genes13101919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 10/14/2022] [Accepted: 10/18/2022] [Indexed: 11/17/2022] Open
Abstract
(1) Background: Genomic testing is increasingly utilized as a clinical tool; however, its integration into nephrology remains limited. The purpose of this study was to identify barriers and prioritize interventions for the widespread implementation of genomics in nephrology. (2) Methods: Qualitative, semi-structured interviews were conducted with 25 Australian adult nephrologists to determine their perspectives on interventions and models of care to support implementation of genomics in nephrology. Interviews were guided by a validated theoretical framework for the implementation of genomic medicine-the Consolidated Framework of Implementation Research (CFIR). (3) Results: Nephrologists were from 18 hospitals, with 7 having a dedicated multidisciplinary kidney genetics service. Most practiced in the public healthcare system (n = 24), a large number were early-career (n = 13), and few had genomics experience (n = 4). The top three preferred interventions were increased funding, access to genomics champions, and education and training. Where interventions to barriers were not reported, we used the CFIR/Expert Recommendations for Implementing Change matching tool to generate theory-informed approaches. The preferred model of service delivery was a multidisciplinary kidney genetics clinic. (4) Conclusions: This study identified surmountable barriers and practical interventions for the implementation of genomics in nephrology, with multidisciplinary kidney genetics clinics identified as the preferred model of care. The integration of genomics education into nephrology training, secure funding for testing, and counselling along with the identification of genomics champions should be pursued by health services more broadly.
Collapse
|
5
|
Veitinger JK, Kerber AS, Gabram-Mendola SGA, Liu Y, Durham LM, Durrence D, Berzen AK, Shin JY, Snyder C, Bellcross CA, Guan Y. Screening for Individuals at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative, Georgia, 2012-2020. Am J Public Health 2022; 112:1249-1252. [PMID: 35862880 PMCID: PMC9382180 DOI: 10.2105/ajph.2022.306932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/03/2022] [Indexed: 11/04/2022]
Abstract
Georgia implemented a statewide family history screening program for hereditary breast and ovarian cancer. From November 2012 through December 2020, 29 090 individuals were screened, 16 679 of whom (57.3%) self-identified as a racial/ethnic minority. Of the 4% (1172/29 090) of individuals who screened as high risk, more than half underwent genetic consultation (793/1172; 67.7%) and testing (416/589; 70.6%). Compared with White women, Black and Hispanic women had higher uptake rates of genetic consultation. Public health settings serving racial minorities are well suited to address disparities in genetic service access. (Am J Public Health. 2022;112(9):1249-1252. https://doi.org/10.2105/AJPH.2022.306932).
Collapse
Affiliation(s)
- Julia K Veitinger
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Alice S Kerber
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Sheryl G A Gabram-Mendola
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Yuan Liu
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Lynn M Durham
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Diane Durrence
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Alissa K Berzen
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Janet Y Shin
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Cindy Snyder
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Cecelia A Bellcross
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| | - Yue Guan
- Julia K. Veitinger is with the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA. Alice S. Kerber, Sheryl G. A. Gabram-Mendola, Lynn M. Durham, and Cindy Snyder are with the Georgia Center for Oncology Research and Education, Atlanta. Yuan Liu is with the Department of Biostatistics and Bioinformatics, Rollins School of Public Health & Winship Cancer Institute, Emory University. Diane Durrence, Alissa K. Berzen, and Janet Y. Shin are with the Georgia Department of Public Health, Atlanta. Cecelia A. Bellcross is with the Department of Human Genetics, Emory University School of Medicine, Atlanta. Yue Guan is with Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University
| |
Collapse
|
6
|
Zhao J, Guan Y, McBride CM. A systematic review of theory-informed strategies used in interventions fostering family genetic risk communication. PATIENT EDUCATION AND COUNSELING 2022; 105:1953-1962. [PMID: 35304074 PMCID: PMC9203975 DOI: 10.1016/j.pec.2022.03.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/31/2021] [Revised: 03/08/2022] [Accepted: 03/09/2022] [Indexed: 05/17/2023]
Abstract
BACKGROUND Inherited risk is a family issue. Identifying family members who carry a pathogenic genetic variant that increases risk of cancers and other chronic diseases can be lifesaving for those affected. OBJECTIVE The research questions are: (1) which family communication frameworks have been applied, (2) how do intervention strategies employed map to these theories, and (3) to what extent were families receptive to these strategies and communication increased? METHODS Manuscripts published between January 2010 and August 2020 were searched in three databases: PubMed, PsycINFO, and Web of Science. RESULTS Nine intervention trials were identified. All interventions were evaluated in clinical genetic counseling contexts using at least one individual-level strategy (e.g. increase knowledge). Only three focused on dyadic conversations such as preparing for relatives' information needs. CONCLUSIONS This systematic review posed the question whether theoretically based approaches have been applied to foster family genetic risk communication. Greater attention needs to be paid to the utilization of dyadic level and family system level theories to guide intervention developments. PRACTICAL IMPLICATIONS We conclude by calling for accelerating and broadening the development of interventions to enable family communication about inherited risk that are theory-based, incorporate family-systems thinking, and are conducted outside of specialty clinic settings.
Collapse
Affiliation(s)
- Jingsong Zhao
- Department of Behavioral, Social and Health Education Sciences, Emory University, GA, USA.
| | - Yue Guan
- Department of Behavioral, Social and Health Education Sciences, Emory University, GA, USA
| | - Colleen M McBride
- Department of Behavioral, Social and Health Education Sciences, Emory University, GA, USA
| |
Collapse
|
7
|
Hardy MW, Peshkin BN, Rose E, Ladd MK, Binion S, Tynan M, McBride CM, Grinzaid KA, Schwartz MD. Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women. J Community Genet 2022; 13:281-292. [PMID: 35486291 PMCID: PMC9051789 DOI: 10.1007/s12687-022-00590-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2022] [Accepted: 04/19/2022] [Indexed: 10/31/2022] Open
Abstract
Pathogenic variants in the BRCA1 and BRCA2 (BRCA1/2) genes are associated with elevated cancer risks in men and women. Due to a founder effect, Ashkenazi Jewish individuals are at higher risk for carrying three specific BRCA1/2 pathogenic variants. There have been recent calls for population screening in this population because many carriers do not have family histories suggestive of hereditary cancer. One approach could be to integrate optional BRCA1/2 testing into routinely offered reproductive carrier screening for recessive and X-linked disorders. However, the differing goals of these types of testing (i.e., personal health risks versus family planning) raise questions about the implications for patient education and informed consent. To this end, we aimed to determine interest, attitudes, and preferences regarding integrating such testing by electronically surveying 331 Ashkenazi Jewish participants in JScreen - a national, not-for-profit, at-home carrier screening program focused on genetic risks in Jewish communities. We found that while 41% of participants had plans to pursue BRCA1/2 testing, 93% would have opted for such testing if offered as an add-on to reproductive carrier screening. This was particularly true of those with higher perceived cancer risk and more positive attitudes toward genetic testing. With respect to preferences about delivery of this service, more than 85% of participants preferred remote (telephone, print, or web-based) genetic education rather than traditional genetic counseling. These results suggest that offering optional BRCA1/2 testing within the context of reproductive carrier screening might provide opportunities for cancer prevention without overburdening scarce genetic counseling resources.
Collapse
Affiliation(s)
- Melanie W Hardy
- Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA
| | - Beth N Peshkin
- Department of Oncology, Georgetown Lombardi Comprehensive Cancer, Georgetown University, 2115 Wisconsin Avenue, Suite 300, Washington, DC, 20007, USA
| | - Esther Rose
- Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA
| | - Mary Kathleen Ladd
- Department of Oncology, Georgetown Lombardi Comprehensive Cancer, Georgetown University, 2115 Wisconsin Avenue, Suite 300, Washington, DC, 20007, USA
| | - Savannah Binion
- Department of Oncology, Georgetown Lombardi Comprehensive Cancer, Georgetown University, 2115 Wisconsin Avenue, Suite 300, Washington, DC, 20007, USA
| | - Mara Tynan
- Department of Oncology, Georgetown Lombardi Comprehensive Cancer, Georgetown University, 2115 Wisconsin Avenue, Suite 300, Washington, DC, 20007, USA
| | - Colleen M McBride
- Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, USA
| | - Karen A Grinzaid
- Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA
| | - Marc D Schwartz
- Department of Oncology, Georgetown Lombardi Comprehensive Cancer, Georgetown University, 2115 Wisconsin Avenue, Suite 300, Washington, DC, 20007, USA.
| |
Collapse
|